US Stock MarketDetailed Quotes

NBSE NeuBase Therapeutics

Watchlist
  • 0.3780
  • 0.00000.00%
Close May 10 16:00 ET
1.42MMarket Cap-55P/E (TTM)

NeuBase Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NeuBase Therapeutics Earnings Date

Currency: USD

Period

Q3 FY2023 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.66

+87.31%
Analyst Rating

No Data

NeuBase Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2022/Q10.000 / 0.000--
--2021/Q40.000 / 0.000--
--2021/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2022/Q10.000 / 0.000--
--2021/Q40.000 / 0.000--
--2021/Q30.000 / 0.000--

Unlock Free Earnings Estimates

NeuBase Therapeutics Earnings Reports

  • NeuBase Therapeutics: Q3 2023 Earnings Report

    Nov 9, 2023 16:11 ET

  • NeuBase Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 14, 2023 16:11 ET

  • NeuBase Therapeutics | 10-QT: Transition report pursuant to Rule 13a-10 or 15d-10 (and amendment thereto)

    Jun 5, 2023 16:05 ET

  • NeuBase Therapeutics | 10-Q: Q1 2023 Earnings Report

    May 11, 2023 16:05 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg